BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burra P, Shalaby S, Zanetto A. Long-term care of transplant recipients: De novo neoplasms after liver transplantation. Curr Opin Organ Transplant. 2018;23:187-195. [PMID: 29324517 DOI: 10.1097/mot.0000000000000499] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Pesthy S, Wegener E, Ossami Saidy RR, Timmermann L, Uluk D, Aydin M, Dziodzio T, Schoening W, Lurje G, Öllinger R, Frost N, Fehrenbach U, Rückert JC, Neudecker J, Pratschke J, Eurich D. Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival. Cancers (Basel) 2022;14:2748. [PMID: 35681728 DOI: 10.3390/cancers14112748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Maurer MM, Ibach M, Plewe J, Winter A, Ritschl P, Globke B, Öllinger R, Lurje G, Schöning W, Pratschke J, Eurich D. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines 2022;10:272. [DOI: 10.3390/biomedicines10020272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Salcedo M, Vinaixa C, Javle M, Trapero-Marugán M, Bustamante J, Line PD. Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference. Transplantation 2022;106:e3-e11. [PMID: 34905758 DOI: 10.1097/TP.0000000000003997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Taborelli M, Shalaby S, Serraino D. De Novo Tumours After Liver Transplantation. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_23] [Reference Citation Analysis]
5 Neuberger J. Long-term Care of the Adult Liver Transplant Recipient. J Clin Exp Hepatol 2022;12:1547-56. [PMID: 36340310 DOI: 10.1016/j.jceh.2022.03.012] [Reference Citation Analysis]
6 Russo FP, Zanetto A. Recurrence of the Primary Liver Disease. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_22] [Reference Citation Analysis]
7 Patel JA, Daoud D, Jain A. Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences. Transplant Rev (Orlando) 2021;36:100670. [PMID: 34688986 DOI: 10.1016/j.trre.2021.100670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lucidi C, Biolato M, Lai Q, Lattanzi B, Lenci I, Milana M, Lionetti R, Liguori A, Angelico M, Tisone G, Avolio AW, Agnes S, Rossi M, Grieco A, Merli M. Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort. Ann Hepatol 2021;24:100309. [PMID: 33482364 DOI: 10.1016/j.aohep.2021.100309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Choudhary NS, Saraf N, Saigal S, Soin AS. Long-term Management of the Adult Liver Transplantation Recipients. J Clin Exp Hepatol 2021;11:239-53. [PMID: 33746450 DOI: 10.1016/j.jceh.2020.06.010] [Reference Citation Analysis]
10 Choudhary NS, Saigal S, Saraf N, Soin AS. Extrahepatic Malignancies and Liver Transplantation: Current Status. J Clin Exp Hepatol 2021;11:494-500. [PMID: 34276155 DOI: 10.1016/j.jceh.2020.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Herzer K, Sterneck M, Welker MW, Nadalin S, Kirchner G, Braun F, Malessa C, Herber A, Pratschke J, Weiss KH, Jaeckel E, Tacke F. Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany. J Clin Med 2020;9:E3570. [PMID: 33167567 DOI: 10.3390/jcm9113570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Shalaby S, Burra P. De novo and recurrent malignancy. Best Pract Res Clin Gastroenterol 2020;46-47:101680. [PMID: 33158464 DOI: 10.1016/j.bpg.2020.101680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Gerasimova OA, Borovik VV, Zherebtsov FK, Granov DA. Extrahepatic malignant neoplasms after liver transplantation: the experience of a single transplant center. RJTAO 2020;21:20-25. [DOI: 10.15825/1995-1191-2019-4-20-25] [Reference Citation Analysis]
14 Line P, Hagness M, Dueland S. Liver Transplantation for CRLM—Is It Ever Indicated? Colorectal Cancer Liver Metastases 2020. [DOI: 10.1007/978-3-030-25486-5_39] [Reference Citation Analysis]
15 Manzia TM, Angelico R, Gazia C, Lenci I, Milana M, Ademoyero OT, Pedini D, Toti L, Spada M, Tisone G, Baiocchi L. De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature. World J Gastroenterol 2019; 25(35): 5356-5375 [PMID: 31558879 DOI: 10.3748/wjg.v25.i35.5356] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]